Item Type | Name |
Concept
|
Cardiovascular Diseases
|
Academic Article
|
Insights from the Women's Health Initiative: individualizing risk assessment for hormone therapy decisions.
|
Academic Article
|
Dietary cholesterol and egg intake in relation to incident cardiovascular disease and all-cause and cause-specific mortality in postmenopausal women.
|
Academic Article
|
Obesity, lipids, cardiovascular risk, and androgen excess.
|
Academic Article
|
The gynecologist and the prevention of cardiovascular disease.
|
Academic Article
|
The gynecologist and cardiovascular disease: a window of opportunity for prevention.
|
Academic Article
|
Endogenous androgens and cardiovascular risk.
|
Academic Article
|
Characterizing cardiovascular risk in women with polycystic ovary syndrome: more than the sum of its parts?
|
Academic Article
|
Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index.
|
Academic Article
|
Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women.
|
Academic Article
|
Polycystic ovarian syndrome: an evidence-based approach to evaluation and management of diabetes and cardiovascular risks for today's clinician.
|
Academic Article
|
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.
|
Academic Article
|
Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials.
|
Academic Article
|
Risk factors: assessment and preventive measures.
|
Academic Article
|
Polycystic ovary syndrome: a risk for coronary artery disease?
|
Academic Article
|
Hysterectomy prevalence and cardiovascular disease risk factors in American Indian women.
|
Academic Article
|
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.
|
Academic Article
|
National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report.
|
Academic Article
|
Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome.
|
Academic Article
|
Metabolic aspects of polycystic ovary syndrome.
|
Academic Article
|
Feasibility and Utility of a Cardiovascular Risk Screening Tool in Women Undergoing Routine Gynecology Evaluation.
|
Academic Article
|
Role of Lipid Management in Women's Health Preventive Care.
|
Academic Article
|
Cardiovascular disease (CVD) risk scores, age, or years since menopause to predict cardiovascular disease in the Women's Health Initiative.
|
Academic Article
|
Association of infertility with atherosclerotic cardiovascular disease among postmenopausal participants in the Women's Health Initiative.
|
Academic Article
|
Body Fat Distribution, Cardiometabolic Traits, and Risk of Major Lower-Extremity Arterial Disease in Postmenopausal Women.
|
Academic Article
|
A Possible Screening Marker for Cardiovascular Disease in Polycystic Ovary Syndrome.
|
Academic Article
|
Managing cardiometabolic risk factors across a woman's lifespan: A lipidologist's perspective.
|
Academic Article
|
Association of Preterm Birth With Prevalent and Incident Hypertension, Early-Onset Hypertension, and Cardiovascular Disease in the Women's Health Initiative.
|
Academic Article
|
The severity of individual menopausal symptoms, cardiovascular disease, and all-cause mortality in the Women's Health Initiative Observational Cohort.
|
Academic Article
|
Pre-diagnosis lipid levels and mortality after obesity-related cancer diagnosis in the Women's Health Initiative cardiovascular disease biomarker cohort.
|
Academic Article
|
Healthy Lifestyle Index and Risk of Cardiovascular Disease Among Postmenopausal Women With Normal Body Mass Index.
|